Tech Company Financing Transactions
Marval Biosciences Funding Round
DFJ Frontier and Mercury Fund joined a $2.5 million Series B venture round for Marval Biosciences. The financing round closed on 10/16/2009.
Transaction Overview
Company Name
Announced On
10/16/2009
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Series B
Investors
Mercury Fund (Daniel Watkins)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1302 Waugh Dr. 842
Houston, TX 77019
USA
Houston, TX 77019
USA
Phone
Website
Email Address
Overview
Marval Biosciences is a developer of a less-toxic dye for computed tomography, or CT, scans.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guy Ezekiel
Chief Financial Officer
Daniel Haimovic
VP - Operations
Karen MacLeod
Browse more venture capital transactions:
Prev: 10/16/2009: Additech venture capital transaction
Next: 10/16/2009: Audience venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs